Back to companies

Merck KGaA: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Merck KGaA (Merck), a subsidiary of E. Merck KG, is a science and technology company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis and infertility; and develops liquid crystal mixtures, organic light-emitting diode (OLED) materials, cosmetic active ingredients, pigments for coatings, and high-tech materials. Merck also provides a wide range of products including lab water systems, gene editing tools, cell lines, antibodies and end-to-end systems. The company serves healthcare, performance materials, and life sciences markets. It has presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.

Headquarters Germany

Address Frankfurter Str. 250, Darmstadt, 64293


Telephone 49 6151 720

No of Employees 61,508

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange MRK (ETR)

Revenue (2021) $23.3B 12.3% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 53.8% (2021 vs 2020)

Market Cap* $23.5B

Net Profit Margin (2021) XXX 37.0% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

890+

Clinical Trials

Determine Merck KGaA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

350+

Catalyst Calendar

Proactively evaluate Merck KGaA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

220+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Merck KGaA’s relevant decision makers and contact details.

170+

Marketed Drugs

Understand Merck KGaA’s commercialized product portfolio to stay one step ahead of the market.

150+

Pipeline Drugs

Identify which of Merck KGaA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

90+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

60+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

50+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

40+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

20+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Merck KGaA and assess market opportunity for new entrants with patient population 8-year forecasts.

20+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services Brands
Prescription Drugs Single-use Manufacturing Apaisyl
Liquid Crystal Mixtures Sterile Filtration Bion
OLED Materials Filtration Concor
XXX XXX XXX
XXX XXX XXX
XXX XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In April, the company entered into an evaluation and option agreement with Biocytogen Pharmaceuticals (Beijing) Co., Ltd to grant them a sole license to evaluate Biocytogen's proprietary antibodies against at least three distinct targets with an option to acquire some of the assets.
2022 Financing Agreements In April, the company invested in vaccines manufacturing facility in Elkton, Virginia, the US.
2022 Acquisitions/Mergers/Takeovers In April, the company acquired Modular Automated Sampling Technology (MAST) platform from Lonza, a pharmaceutical, biotechnology and nutrition producing company.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Merck KGaA BASF SE Novartis AG GlaxoSmithKline Plc Sanofi
Headquarters Germany Germany Switzerland United Kingdom France
City Darmstadt Ludwigshafen Am Rhein Basel Brentford Paris
No. of Employees 61,508 110,828 110,000 90,096 95,442
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Net Income Growth

Image for loader
Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Kai Beckmann Chief Executive Officer - Electronics business; Director Executive Board 2017 57
Belen Garijo Chief Executive Officer Senior Management 2021 -
Peter Guenter Chief Executive Officer - Healthcare Senior Management 2021 -
Alessandro de Luca Head - Information Technology; Chief Information Officer - Group Senior Management 2021 -
Matthias Heinzel Chief Executive Officer - Life Science Senior Management 2021 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer